Suppr超能文献

使用常见药物时,苯环己哌啶尿检出现假阳性的频率有多高?

How often do false-positive phencyclidine urine screens occur with use of common medications?

机构信息

Division of Emergency Medicine, Washington University, St. Louis, MO 63110, USA.

出版信息

Clin Toxicol (Phila). 2013 Jul;51(6):493-6. doi: 10.3109/15563650.2013.801982. Epub 2013 May 23.

Abstract

BACKGROUND

Previous reports describe false-positive urine immunoassay screens for phencyclidine (PCP) associated with use of tramadol, dextromethorphan, or diphenhydramine. The likelihood of these false positives is unknown.

OBJECTIVE

We sought to find the relative frequency of false-positive PCP screens associated with these medications and to look for any other medications with similar associations.

METHODS

In an IRB-approved study, we retrospectively reviewed charts of all ED encounters with positive urine screens for PCP in our hospital from 2007 through 2011, inclusive. Urine samples were tested for drugs of abuse using the Siemens Syva EMIT II Immunoassay. Our laboratory routinely confirmed all positive screens using GC-MS with results classified as either "confirmed" (true positive) or "failed to confirm" (false positive). We recorded all medications mentioned in the chart as current medications or medications given before the urine sample. We used Fisher's exact test to compare frequencies of tramadol, dextromethorphan, diphenhydramine, and other medications between the two groups.

RESULTS

Tramadol, dextromethorphan, alprazolam, clonazepam, and carvedilol were significantly more frequent among the false-positive group, but the latter three were also associated with polysubstance abuse. Diphenhydramine was more frequently recorded among the false-positive group, but this was not statistically significant.

CONCLUSION

False-positive urine screens for PCP are associated with tramadol and dextromethorphan and may also occur with diphenhydramine. Positive PCP screens associated with alprazolam, clonazepam, and carvedilol were also associated with polysubstance abuse.

摘要

背景

先前的报告描述了与曲马多、右美沙芬或苯海拉明使用相关的苯环利定尿液免疫分析假阳性。这些假阳性的可能性尚不清楚。

目的

我们试图确定与这些药物相关的苯环利定尿液假阳性的相对频率,并寻找其他具有类似关联的药物。

方法

在一项经过 IRB 批准的研究中,我们回顾性地审查了我们医院 2007 年至 2011 年期间所有急诊尿液苯环利定阳性的 ED 就诊记录。尿液样本使用 Siemens Syva EMIT II 免疫分析法进行药物滥用检测。我们的实验室常规使用 GC-MS 对所有阳性筛查进行确认,结果分为“确认”(真阳性)或“未确认”(假阳性)。我们记录了图表中提到的所有当前药物或尿液样本之前使用的药物。我们使用 Fisher's 确切检验比较了假阳性组和真阳性组中曲马多、右美沙芬、苯海拉明和其他药物的频率。

结果

曲马多、右美沙芬、阿普唑仑、氯硝西泮和卡维地洛在假阳性组中更为常见,但后三者也与多药物滥用有关。苯海拉明在假阳性组中更为常见,但这没有统计学意义。

结论

苯环利定尿液假阳性与曲马多和右美沙芬有关,也可能与苯海拉明有关。与阿普唑仑、氯硝西泮和卡维地洛相关的苯环利定阳性筛查也与多药物滥用有关。

相似文献

8

引用本文的文献

9
Objective Testing: Urine and Other Drug Tests.客观检测:尿液及其他药物检测。
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):549-65. doi: 10.1016/j.chc.2016.02.005. Epub 2016 Mar 30.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验